WayneMarstonClarkMD

Neurology • Portland, OR

Interventional Neurology, Vascular Neurology

Professor, Neurology, Oregon Health & Science University School of Medicine

Join to view full profile

Dr. Clark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Clark's full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239
Phone+1 503-494-7772

Education & Training

University of California (San Diego) Medical CenterResidency, Neurology, 1986 - 1990
Legacy Health/Emanuel Medical CenterInternship, Internal Medicine, 1985 - 1986
Oregon Health and Science University School of MedicineClass of 1985

Certifications & Licensure

CA State Medical License 1986 - Present
WA State Medical License 2020 - 2027
OR State Medical License 1990 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) Start of enrollment: 2000 Dec 01
Completed
Phase 2
A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients Start of enrollment: 2000 Dec 01
Completed
Phase 2
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke Start of enrollment: 2002 Nov 01
Terminated
Phase 2, Phase 3
Albumin in Acute Ischemic Stroke Trial Start of enrollment: 2006 Jun 01
Terminated
Phase 3
Neuroprotection With Minocycline Therapy for Acute Stroke Recovery Trial Start of enrollment: 2009 Jul 01
Terminated
Phase 4
ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients Start of enrollment: 2011 Oct 01
Suspended
Not Applicable
Trevo® Retriever Registry Post Market Surveillance Start of enrollment: 2013 Nov 25
Completed
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial Start of enrollment: 2014 Dec 09
Recruiting
Not Applicable
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Start of enrollment: 2018 Jan 19
Terminated
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Low body mass index patients have worse outcomes after mechanical thrombectomy.
Adeline L Fecker, Maryam N Shahin, Samantha Sheffels, Joseph Girard Nugent, Daniel Munger
Journal of Neurointerventional Surgery. 2024-10-14
37 citations
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.
Hooman Kamel, W T Longstreth Jr, David L Tirschwell, Richard A Kronmal, Randolph S Marshall
JAMA. 2024-02-20
3 citations
Thrombectomy With the pRESET vs Solitaire Stent Retrievers as First-Line Large Vessel Occlusion Stroke Treatment: A Randomized Clinical Trial.
Raul G Nogueira, Donald Lobsien, Joachim Klisch, Daniel Pielenz, Elmar Lobsien
JAMA Neurology. 2024-02-01

Press Mentions

Baby Boomers in RetirementMarch 11th, 2020
Study: New Treatment Could Help Stroke PatientsApril 6th, 2017
Pill to Prevent Strokes Also Prevents Diabetes, Study ShowsFebruary 18th, 2016
Join now to see all